Gut Microbiota (GM) dysbiosis associates with Atherosclerotic Cardiovascular Diseases (ACVD), but whether this also holds true in subjects without clinically manifest ACVD represents a challenge of personalized prevention. We connected exposure to diet (self-reported by food dia-ries) and markers of Subclinical Carotid Atherosclerosis (SCA) with individual taxonomic and functional GM profiles (from fecal metagenomic DNA) of 345 subjects without previous clinically manifest ACVD. Subjects without SCA reported consuming higher amounts of cereals, starchy vegeta-bles, milky products, yoghurts and bakery products versus those with SCA (who reported to con-sume more mechanically separated meats). The variety of dietary sources significantly overlapped with the separations in GM composition between subjects without SCA and those with SCA (RV coefficient between nutrients quantities and microbial relative abundances at genus level = 0.65, p-value = 0.047). Additionally, specific bacterial species (Faecalibacterium prausnitzii in the absence of SCA and Escherichia coli in the presence of SCA) are directly related to over-representation of meta-genomic pathways linked to different dietary sources (sulfur oxidation and starch degradation in absence of SCA, and metabolism of amino acids, syntheses of palmitate, choline, carnitines and Trimethylamine n-oxide in presence of SCA). These findings might contribute to hypothesize future strategies of personalized dietary intervention for primary CVD prevention setting.

Gut microbiota functional dysbiosis relates to individual diet in subclinical carotid atherosclerosis / A. Baragetti, M. Severgnini, E. Olmastroni, C.C. Dioguardi, E. Mattavelli, A. Angius, L. Rotta, J. Cibella, G. Caredda, C. Consolandi, L. Grigore, F. Pellegatta, F. Giavarini, D. Caruso, G.D. Norata, A.L. Catapano, C. Peano. - In: NUTRIENTS. - ISSN 2072-6643. - 13:2(2021 Jan 21), pp. 304.1-304.19. [10.3390/nu13020304]

Gut microbiota functional dysbiosis relates to individual diet in subclinical carotid atherosclerosis

A. Baragetti
Primo
Conceptualization
;
M. Severgnini
Secondo
;
E. Olmastroni;E. Mattavelli;A. Angius;J. Cibella;G. Caredda;C. Consolandi;F. Pellegatta;F. Giavarini;D. Caruso;G.D. Norata
Membro del Collaboration Group
;
A.L. Catapano
Penultimo
Conceptualization
;
2021

Abstract

Gut Microbiota (GM) dysbiosis associates with Atherosclerotic Cardiovascular Diseases (ACVD), but whether this also holds true in subjects without clinically manifest ACVD represents a challenge of personalized prevention. We connected exposure to diet (self-reported by food dia-ries) and markers of Subclinical Carotid Atherosclerosis (SCA) with individual taxonomic and functional GM profiles (from fecal metagenomic DNA) of 345 subjects without previous clinically manifest ACVD. Subjects without SCA reported consuming higher amounts of cereals, starchy vegeta-bles, milky products, yoghurts and bakery products versus those with SCA (who reported to con-sume more mechanically separated meats). The variety of dietary sources significantly overlapped with the separations in GM composition between subjects without SCA and those with SCA (RV coefficient between nutrients quantities and microbial relative abundances at genus level = 0.65, p-value = 0.047). Additionally, specific bacterial species (Faecalibacterium prausnitzii in the absence of SCA and Escherichia coli in the presence of SCA) are directly related to over-representation of meta-genomic pathways linked to different dietary sources (sulfur oxidation and starch degradation in absence of SCA, and metabolism of amino acids, syntheses of palmitate, choline, carnitines and Trimethylamine n-oxide in presence of SCA). These findings might contribute to hypothesize future strategies of personalized dietary intervention for primary CVD prevention setting.
Atherosclerotic Cardiovascular Diseases; Gut Microbiota; Next generation sequencing
Settore BIO/14 - Farmacologia
   Potere pro-infiammatorio della dieta sulla composizione del microbiota intestinale e relazione con la malattia cardiovascolare ischemica
   UNIVERSITA' DEGLI STUDI DI TORINO

   Integrating metabolism and immunity: cellular and molecular pathways leading to metabolic dysregulation and autoimmunity
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2017K55HLC_003

   Immunometabolic effects of apolipoprotein E: focus on the modulation of cholesterol metabolism in antigen presenting cells
   FONDAZIONE CARIPLO
   2015-0524

   Proprotein convertase subtilisin/kexin type 9 (PCSK9): a link between lipotoxicity, mitochondrial dysfunction, and frailty-associated heart failure
   FONDAZIONE CARIPLO
   2016-0852

   Low density lipoprotein receptor (LDLR)-independent effects of proprotein convertase subtilisin/kexin type 9 (PCSK9): role in modulating insulin-resistance, ectopic fat accumulation and low-grade inflammation
   MINISTERO DELL'ISTRUZIONE E DEL MERITO
   2017H5F943_001
21-gen-2021
Article (author)
File in questo prodotto:
File Dimensione Formato  
Baragetti A et al. Nutrients 2021.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 2.19 MB
Formato Adobe PDF
2.19 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/831365
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
social impact